Silperisone
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152044This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R16SK8726X. European Medicines Agency schedules Silperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10521MIG. Silperisone generally arises in the molecular formula C15H24FNSI. The term SILPERISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) SILPERISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule silperisone under HS 29333999 and SITC 51574. As of Q4 2014, SILPERISONE remains the US FDA Preferred Term for this commodity. Silperisone bears US NLM identifiers UMLS ID C1101150 and NCI Concept Code C74281. SMILES: [SI](CN1CCCCC1)(CC1CCC(F)CC1)(C)C.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.